| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/11/1999 | WO1999012027A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof |
| 03/11/1999 | WO1999011824A1 An alpha-2 macroglobulin diagnostic test |
| 03/11/1999 | WO1999011819A1 Improved detection of mutations in nucleic acids by chemical cleavage |
| 03/11/1999 | WO1999011818A1 Method for detecting highly functional polypeptides or nucleic acids |
| 03/11/1999 | WO1999011817A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53 |
| 03/11/1999 | WO1999011813A2 Oligonucleotide probes bearing quenchable fluorescent labels, and methods of use thereof |
| 03/11/1999 | WO1999011811A1 Methods of measuring gene expression using wax-embedded tissue specimens |
| 03/11/1999 | WO1999011809A1 Conjugates that contain the homeodomain of antennapedia |
| 03/11/1999 | WO1999011808A1 Rna respiratory syncytial virus vaccines |
| 03/11/1999 | WO1999011807A1 Selective expression of genes in plants |
| 03/11/1999 | WO1999011806A1 Pathogen-resistant transgenic plants and methods of making |
| 03/11/1999 | WO1999011805A1 Recombinant dna molecules and method for increasing oil content in plants |
| 03/11/1999 | WO1999011804A2 Ethanol production by mutant yeast |
| 03/11/1999 | WO1999011803A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria |
| 03/11/1999 | WO1999011802A1 Autonomous parvovirus-based vectors and their use |
| 03/11/1999 | WO1999011801A2 Protease based gene switching system |
| 03/11/1999 | WO1999011800A1 GENE ENCODING α-SUBUNIT OF RICE ANTHRANILATE SYNTHASE AND DNA RELATING THERETO |
| 03/11/1999 | WO1999011799A2 Human aminopeptidase p gene |
| 03/11/1999 | WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/11/1999 | WO1999011797A1 Gene |
| 03/11/1999 | WO1999011796A1 Hnk-1 sulfotransferase and methods of use therefor |
| 03/11/1999 | WO1999011795A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods |
| 03/11/1999 | WO1999011794A2 New vrk1 kinase |
| 03/11/1999 | WO1999011793A1 HUMAN actVA-ORF4-LIKE PROTEIN |
| 03/11/1999 | WO1999011792A1 Single-stranded antibody against hepatitis b virus core protein, gene thereof, and therapeutic agent for hepatitis b containing these |
| 03/11/1999 | WO1999011791A2 Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| 03/11/1999 | WO1999011790A1 Tumor necrosis factor receptor ztnfr-6 |
| 03/11/1999 | WO1999011789A1 Genetic engineering of cells to enhance healing and tissue regeneration |
| 03/11/1999 | WO1999011788A1 Kringle1 |
| 03/11/1999 | WO1999011787A1 DNA PARTICIPATING IN REGULATION OF EXPRESSION O PEBP2 αA GENE, AND USE THEREOF |
| 03/11/1999 | WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY |
| 03/11/1999 | WO1999011785A1 Chimeric binding peptide library screening method |
| 03/11/1999 | WO1999011784A1 Proton gated ion channel proteins |
| 03/11/1999 | WO1999011783A2 T-box polypeptides |
| 03/11/1999 | WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 03/11/1999 | WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile |
| 03/11/1999 | WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
| 03/11/1999 | WO1999011779A1 Dna sequences enhancing promoter activity |
| 03/11/1999 | WO1999011778A1 Antisense treatment of pulmonary hypertension |
| 03/11/1999 | WO1999011777A1 Methods for protein screening |
| 03/11/1999 | WO1999011774A1 Polypeptides comprising a coiled-coil and an addition site |
| 03/11/1999 | WO1999011773A1 Transgenic mammals which produce oligosaccharides in their milk |
| 03/11/1999 | WO1999011772A1 Transgenic animals for the study of biological, physical and chemical toxic agents |
| 03/11/1999 | WO1999011770A1 Protease variants and compositions |
| 03/11/1999 | WO1999011769A1 Protease variants and compositions |
| 03/11/1999 | WO1999011768A1 Protease variants and compositions |
| 03/11/1999 | WO1999011765A1 Cytochrome p450 reductases from poppy plants |
| 03/11/1999 | WO1999011764A2 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/11/1999 | WO1999011761A1 Suspension culture of retroviral producer cells |
| 03/11/1999 | WO1999011760A1 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ERα AND ERβ AT AP1 SITES |
| 03/11/1999 | WO1999011759A1 GLUCOSE RESPONSIVE β-CELL LINE |
| 03/11/1999 | WO1999011758A2 Cultures of human cns neural stem cells |
| 03/11/1999 | WO1999011757A1 NUCLEIC AND AMINO ACID SEQUENCES FOR A NOVEL TRANSKETOLASE FROM $i (MENTHA PIPERITA) |
| 03/11/1999 | WO1999011754A1 Dna capillary |
| 03/11/1999 | WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 03/11/1999 | WO1999011676A1 Formulation |
| 03/11/1999 | WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 03/11/1999 | WO1999011665A1 Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same |
| 03/11/1999 | WO1999011664A1 Genetically engineered cells which express bone morphogenetic proteins |
| 03/11/1999 | WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/11/1999 | WO1999011661A1 Biomolecules comprising an elastomeric peptide |
| 03/11/1999 | WO1999011652A1 Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression |
| 03/11/1999 | WO1999011293A1 50 human secreted proteins |
| 03/11/1999 | WO1999011292A2 Compositions and methods for treating arthritis utilizing gene therapy |
| 03/11/1999 | WO1999011288A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 03/11/1999 | WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 03/11/1999 | WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals |
| 03/11/1999 | WO1998058086A3 Nucleic acid primers and probes for detecting hiv-1 and hiv-2 |
| 03/11/1999 | WO1998058083A3 Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| 03/11/1999 | WO1998057990A3 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
| 03/11/1999 | WO1998057986A3 Human preprotachykinin b |
| 03/11/1999 | WO1998057984A3 Torsin, torsin genes, and methods of use |
| 03/11/1999 | WO1998056937A3 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 03/11/1999 | WO1998056935A3 Plant amino acid biosynthetic enzymes |
| 03/11/1999 | WO1998055512A3 Smad-interacting polypeptides and their use |
| 03/11/1999 | WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain |
| 03/11/1999 | WO1998054331A3 High level expression of glycosyltransferases |
| 03/11/1999 | WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
| 03/11/1999 | WO1998053104A3 Detection of retroviral subtypes based upon envelope specific sequences |
| 03/11/1999 | WO1998050547A3 Human toll-like receptor proteins, related reagents and methods |
| 03/11/1999 | WO1998049300A3 Truncated vegf-related proteins |
| 03/11/1999 | WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 03/11/1999 | WO1998033509A3 Useful properties of human lactoferrin and variants thereof |
| 03/11/1999 | DE19740384A1 Antisense oligonucleotides specific for protein kinase C isoforms |
| 03/11/1999 | DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile |
| 03/11/1999 | DE19739611A1 Nucleinsäure-Sequenzen und Verfahren zum Nachweis von Bakterien der Gattung Pseudomonas Nucleic acid sequences and methods for detecting bacteria of the genus Pseudomonas |
| 03/11/1999 | DE19738816A1 Verfahren zur Markierung von festen, flüssigen oder gasförmigen Substanzen A method for marking solid, liquid or gaseous substances |
| 03/11/1999 | CA2830694A1 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/11/1999 | CA2682108A1 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 03/11/1999 | CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile |
| 03/11/1999 | CA2303418A1 Dna participating in regulation of expression o pebp2 .alpha.a gene, and use thereof |
| 03/11/1999 | CA2302865A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria |
| 03/11/1999 | CA2302830A1 Glucose responsive .beta.-cell line |
| 03/11/1999 | CA2302829A1 An alpha-2 macroglobulin diagnostic test |
| 03/11/1999 | CA2302777A1 Transgenic mammals which produce oligosaccharides in their milk |
| 03/11/1999 | CA2302484A1 Cultures of human cns neural stem cells |
| 03/11/1999 | CA2302471A1 Selective expression of genes in plants |
| 03/11/1999 | CA2302403A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 03/11/1999 | CA2302394A1 Polypeptides comprising a coiled-coil and an addition site |
| 03/11/1999 | CA2302220A1 Transgenic animals for the study of biological, physical and chemical toxic agents |